γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Conditions:   Non-Hodgkin's Lymphoma;   Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma;   Chronic Lymphoblastic Leukemia;   Peripheral T Cell Lymphoma Intervention:   Biological: Autologous γδT cells Sponsors:   Institute of Hematology & Blood Diseases Hospital;   Beijing GD Initiative Cell Therapy Technology Co.，Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials